Today: 21 May 2026
Intel stock price whipsaws after earnings as weak outlook collides with supply squeeze
22 January 2026
2 mins read

Intel stock price whipsaws after earnings as weak outlook collides with supply squeeze

New York, Jan 22, 2026, 4:36 PM EST — After-hours

  • Intel shares climbed 0.2% in after-hours action, bouncing back after a volatile reaction to its earnings and forecast.
  • The chipmaker warned that first-quarter revenue would fall short of Wall Street expectations, citing supply constraints.
  • Traders are focused on management’s update regarding the 18A ramp and foundry demand.

Intel (INTC.O) shares climbed 0.2% to $54.32 in after-hours trading Thursday, swinging between $50.17 and $55.29 as traders absorbed the quarterly earnings report.

This move is significant since Intel’s shares have been surging ahead of the earnings, driven by optimism around an “AI server CPU” comeback and early progress in its manufacturing efforts. The real snag came not from the quarter itself, but from the outlook.

Intel projected first-quarter revenue between $11.7 billion and $12.7 billion, with the midpoint falling short of analysts’ estimates. This comes despite the company beating forecasts in the December quarter, Barron’s reports.

Intel reported fourth-quarter revenue of $13.7 billion, down 4% from the prior year, with non-GAAP EPS coming in at $0.15. CEO Lip-Bu Tan highlighted the launch of Intel’s first products on its 18A process, adding the company is “working aggressively to grow supply.” CFO David Zinsner noted supply will hit its “lowest level in Q1” before seeing improvement later. Intel Corporation

Thursday’s setup was anything but smooth. Intel shares surged almost 12% Wednesday, finishing above $54. The jump came after a handful of Wall Street firms flagged stronger-than-expected demand for Intel’s server CPUs and a more optimistic outlook ahead of the earnings report.

Seaport Research’s Jay Goldberg upgraded Intel to “buy,” setting a $65 price target. He believes the new Panther Lake lineup will boost Intel’s products business soon and help the company “retake share” this year. TipRanks

HSBC upgraded Intel’s rating to “hold” from “reduce,” boosting the price target to $50 from $26. The bank pointed to anticipated growth in Intel’s server segment driven by “agentic AI” demand, according to an Investing.com report.

Intel unveiled Panther Lake, a laptop chip crafted on its 18A manufacturing process, earlier this month at CES. The company is positioning it as a game-changer in its battle to regain market share from AMD.

Competitive pressure remains intense. Intel goes head-to-head with AMD in PCs and servers, while also competing across the wider data-center silicon market. Meanwhile, its foundry division is working to persuade external clients to have confidence in Intel’s manufacturing roadmap.

Downside risks are clear: should supply chain issues drag on beyond Intel’s projections, or if the 18A rollout delays, short-term revenue could take a hit despite steady demand. Intel’s challenges with 18A execution aren’t new, Reuters has noted.

Traders are turning to Tan and Zinsner to clarify exactly what’s bottlenecked—tools, substrates, packaging, or another factor—how fast supply might loosen in Q2, and if Intel can turn its “foundry traction” into steady orders.

Intel’s next key event is just around the corner: the company will hold its earnings call at 2 p.m. PT this Thursday. Investors are expected to push for clearer timelines on supply issues, 18A capacity, and updates on foundry customer developments.

Stock Market Today

  • Sharda Cropchem Earnings Reveal Weak Cash Flow Despite Profit Growth
    May 20, 2026, 9:35 PM EDT. Sharda Cropchem Limited's (NSE:SHARDACROP) recent earnings report shows a statutory profit of ₹6.81 billion for the year ending March 2026, but free cash flow was significantly lower at ₹1.6 billion, resulting in a high accrual ratio of 0.23. This suggests the company's cash conversion is less than ideal, raising concerns about the sustainability of its earnings. Despite this, Sharda Cropchem's earnings per share (EPS) has grown impressively over the past three years. Investors remain cautious due to three warning signs surrounding the stock, with one marked as significant. The gap between profit and cash flow indicates that reported profits may overstate the company's underlying earning power.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Lemonade stock jumps again on Tesla FSD insurance cut, with rollout days away
Previous Story

Lemonade stock jumps again on Tesla FSD insurance cut, with rollout days away

Abbott stock sinks 10% after outlook misses estimates — what ABT investors watch next
Next Story

Abbott stock sinks 10% after outlook misses estimates — what ABT investors watch next

Go toTop